![[höher]](/style/images/multi_up.png)
Eine Ebene höherGruppiert nach:
Dokumententyp
| Veröffentlichungsdatum
Springe zu: Zeitschriftenartikel
Anzahl der Publikationen: 3
Zeitschriftenartikel
Heidegger, Isabel; Kesch, Claudia; Kretschmer, Alexander; Tsaur, Igor; Ceci, Francesco; Valerio, Massimo; Tilki, Derya; Marra, Giancarlo; Preisser, Felix; Fankhauser, Christian D.; Zattoni, Fabio; Chiu, Peter; Puche-Sanz, Ignacio; Olivier, Jonathan; Bergh, Roderik C. N. van den; Kasivisvanathan, Veeru; Pircher, Andreas; Virgolini, Irene und Gandaglia, Giorgio
(2022):
Biomarkers to personalize treatment with 177Lu-PSMA-617 in men with metastatic castration-resistant prostate cancer-a state of the art review.
In: Therapeutic Advances in Medical Oncology, Bd. 14
Heidegger, Isabel; Necchi, Andrea; Pircher, Andreas; Tsaur, Igor; Marra, Giancarlo; Kasivisvanathan, Veeru; Kretschmer, Alexander; Mathieu, Romain; Ceci, Francesco; Bergh, Roderick C. N. van den; Thibault, Constance; Tilki, Derya; Valerio, Massimo; Surcel, Christian und Gandaglia, Giorgio
(2021):
A Systematic Review of the Emerging Role of Immune Checkpoint Inhibitors in Metastatic Castration-resistant Prostate Cancer: Will Combination Strategies Improve Efficacy?
In: European Urology Oncology, Bd. 4, Nr. 5: S. 745-754
Kocher, Florian; Tymoszuk, Piotr; Amann, Arno; Sprung, Susanne; Salcher, Stefan; Daum, Sophia; Haybaeck, Johannes; Rinnerthaler, Gabriel; Huemer, Florian; Kauffmann-Guerrero, Diego; Tufman, Amanda; Seeber, Andreas; Wolf, Dominik und Pircher, Andreas
(2021):
Deregulated glutamate to pro-collagen conversion is associated with adverse outcome in lung cancer and may be targeted by renin-angiotensin-aldosterone system (RAS) inhibition.
In: Lung Cancer, Bd. 159: S. 84-95